EP06.05-09 Computational Pathology-Based Assessment of cMET IHC Expression for Patient Selection in the Treatment of MET Overexpressing NSCLC
Year: 2023
Type: conference-abstract
Source: Journal of Thoracic Oncology
Authors: S. Christ, A. Kapil, I. Bisha, J. Chan, A. Andoni, C. Cotoi, M. Schick, G. Schmidt, R. Hartmaier, H. Sade
Institution: AstraZeneca (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4388044194